NASDAQ:TFFP
Tff Pharmaceuticals, Inc. Stock News
$2.09
-0.110 (-5.00%)
At Close: May 08, 2024
TFF Pharmaceuticals to Present at Virtual Investor Conferences in March 2021
09:00am, Friday, 05'th Mar 2021
AUSTIN, Texas--(BUSINESS WIRE)---- $TFFP--TFF Pharmaceuticals to Present at the upcoming H.C. Wainwright Global Life Sciences Conference and the 33rd Annual ROTH Conference in March.
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021
08:30am, Wednesday, 24'th Feb 2021
AUSTIN, Texas--(BUSINESS WIRE)---- $TFFP #earnings--TFF Pharmaceuticals to hold its fourth quarter and full-year 2020 financial results and business results conference call on March 10, 2021.
AUSTIN, Texas--(BUSINESS WIRE)---- $TFFP #Ebola--TFF Pharmaceuticals reports positive preclinical results with two biodefense countermeasures for the Army's USAMRIID laboratories.
TFF Pharmaceuticals to Present at the BIO CEO & Investor Digital Conference
08:30am, Friday, 12'th Feb 2021
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its pat
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call Transcript
02:38am, Monday, 09'th Nov 2020
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call Transcript
TFF Pharmaceuticals - Game-Changing Drug Reformulation Technology
09:53am, Tuesday, 27'th Oct 2020
TFF possess the rights to a game-changing drug formulation technology. They have a cost-efficient, fast route to market for their improved drugs.
